Cell-Surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss

American Journal of Reproductive Immunology

Volumn 61, Issue 1, 2009, Pages 75-84

  Clark, David A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

CD200; Immunotherapy; Infertility; Recurrent spontaneous abortion; Tolerance; Transfusionrelated immunomodulation

Indexed keywords

ACETYLSALICYLIC ACID; CD200 ANTIGEN; GAMMUNEX; HEPARIN; IMMUNOGLOBULIN G; PREDNISONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LEUKOCYTE COUNT; LIVE BIRTH; MALE; MONONUCLEAR CELL; OBSERVATIONAL STUDY; PILOT STUDY; PREDICTION; PREGNANCY; PRIORITY JOURNAL; RECURRENT ABORTION; SPONTANEOUS ABORTION; THERAPY EFFECT; TREATMENT OUTCOME;

ABORTION, HABITUAL; ADULT; ANTIGENS, CD; CELL MEMBRANE; FEMALE; HUMANS; IMMUNOTHERAPY; LEUKOCYTES, MONONUCLEAR;

EID: 57749195131     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00665.x     Document Type: Article

References (47)

1. Recurrent miscarriage immunotherapy Trialists group (RMITG): Worldwide prospective observational study and meta-analysis on allogeneic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1994; 32:55-72.
2. Daya S, Gunby J, the Recurrent Miscarriage Immunotherapy Trialists Group: The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent abortion. Am J Reprod Immunol 1994; 32:294-302.
3. Clark DA, Daya S, Coulam CB, Gunby J, the Recurrent Miscarriage Immunotherapy Trialists Group: Implications of abnormal human trophoblast karyotype for the evidence-based approach to the understanding, investigation, and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1996; 35:495-498.
4. Clark DA, Coulam CB, Daya S, Chaouat G: Unexplained sporadic and recurrent miscarriage in the new millennium: A critical analysis of immune mechanisms and treatment. Hum Reprod Update 2001; 7:501-511.
5. Clark DA: Immunological factors in preFnancy wastage: fact or fiction. Am J Reprod Immunol 2008; 59:277-300.
6. Clark DA: Shall we properly re-examine the status of allogeneic lymphocyte immunotherapy for recurrent pregnancy failure? Am J Reprod Immunol 2004; 51:7-15.
7. Clark DA, Ding JW, Yu G, Levy GA, Gorczynski RM: Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2. Mol Hum Reprod 2001; 7:185-194.
8. Clark DA, Keil A, Chen Z, Markert U, Manuel J, Gorczynski RM: Placental trophoblast from successful human pregnancies expresses the tolerance signaling molecule CD200 (OX-2). Am J Reprod Immunol 2003; 50:187-195.
9. Gorczynski R, Chen Z, Clark DA, Yu K, Lee L, Nachman J, Wong S, Marsden P: Structural and functional heterogeneity in the CD200 R family of immunoregulatory molecules at the feto-maternal interface. Am J Reprod Immunol 2004; 52:147-163.
10. Yu G, Sun Y, Foerster K, Manuel J, Molina H, Levy GA, Gorczynski RM, Clark DA: LPS-induced murine abortions require C5 but not C3, and are presented by up-regulating expression of the CD200 tolerance signaling molecule. Am J Reprod Immunol 2008; 60:135-140
11. Clark DA, Gorczynski RM, Blajchman MA: Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen: Stimulation of tumor nodule formation and growth by TGF-β in a murine model. Transfusion 2008; 48:814-821.
12. Clark DA, Chaouat G: Loss of surface CD200 on stored allogeneic leukocytes may impair anti-abortive effect in vivo. Am J Reprod Immunol 2005; 53:13-20.
13. Ober C, Karrison T, Odem RR, Barnes RB, Branch DW, Stephenson MD, Baron R, Walker MA, Scott JR, Schreiber JR: Mononuclear-cell immunization in prevention of recurrent miscarriages: A randomized trial. Lancet 1999; 354:365-369.
14. Pandey MK, Agrawal S: Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. Int Immunopharmacol 2004; 4:289-298.
15. Mowbray JF: Immunology of early pregnancy. Hum Reprod 1988; 3:79-82.
16. Clark DA: Is there any evidence for immunologically mediated or immunologically modifiable early pregnancy failure? J Assist Reprod Genet 2003; 20:63-72.
17. Clark DA, Coulam CB, Stricker RM: Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). J Assist Reprod Genet 2006; 23:1-13 (Erratum 23:383).
18. Aoki K, Kajijura S, Matsumoto Y, Ogasawara M, Okada S, Yamagi Y, Gleicher N: Preconceptional natural killer cell activity as a predictor of miscarriage. Lancet 1995; 135:1340-1342.
19. + cells can predict pregnancy outcome. Am J Reprod Immunol 1995; 33:40-46.
20. Coulam CB, Roussev RG: Correlation of NK cell activation and inhibition markers with NK cytotoxicity among women experiencing immunological implantation failure after in vitro fertilization and embryo transfer. J Assist Reprod Genet 2003; 30:58-62.
21. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivales EI, Mangubat CP, Beaman KD, Beer AE, Gillman-Sachs A: Increased T helper 1 cytokine responses in circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767-773.
22. Coulam CB, Roussev RG: Increasing circulating T-cell activation markers are linked to subsequent implantation failure after transfer of in vitro fertilized embryos. Am J Reprod Immunol 2003; 50:340-345.
23. + NK cells is associated with a poorer IVF treatment and pregnancy outcome. Hum Reprod 2004; 19: 2395-2400.
24. Thum M-Y, Bhaskaran S, Abdalla HA, Ford B, Sumar N, Bansal A: Prednisolone suppresses NK cell cytotoxicity in women with a history of infertility and NK cell cytotoxicity. Am J Reprod Immunol 2008; 59:259-265.
25. Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H: Preconceptional natural killer activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with a normal karyotype. Am J Reprod Immunol 2003; 50:351-354.
26. Hasegawa I, Yamamoto Y, Suzuki M, Murakawa H, Kurabayashi T, Takakuwa K, Tanaka K: Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Fertil Steril 1998; 70:1044-1048.
27. Check JH, Liss JR, Check ML, Diantonio A, Duroseau M: Lymphocyte immunotherapy can improve pregnancy outcome following embryo transfer (ET) in patients failing to conceive after two previous ET. Clin Exp Obstet Gynecol 2005; 32:21-22.
28. Check JH, Liss J, Check ML, Diantonio A, Choe JK, Graziano V: Leukocyte immunotherapy improves live delivery rates following embryo transfer in women with at least two previous failures: A retrospective review. Clin Exp Obstet Gynecol 2005; 32:85-88.
29. Check JH, Liss JR, Diantonio A, Check ML, Duroseu M: Matched control study of efficacy of lymphocyte immunotherapy in donor oocyte recipients to support or refute the concept of need for histocompatibility antigen sharing of the couple for benefit. Clin Exp Obstet Gynecol 2005; 32:155-157.
30. Smith JB, Cowchock FS, Lata JA, Hankinson BT, Iftekhar A, Rote NS: Pregnancy outcome after immunotherapy is influenced by the number of cells in the innoculum. Am J Reprod Immunol 1990; 22:88.
31. Clark DA, Daya S: Trials and tribulation in the treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1991; 25:18-24.
32. Mowbray JF, Underwood JL: Effect of paternal lymphocyte immunization on birthweight and pregnancy outcome: In Cellular and Molecular Biology of the Materno-Fetal Relationship, G Chaouat, JF Mowbray (eds). Paris, John Libby Eurotext, INSERM Colloque 212, 1991, pp 295-302.
33. Daya S: Human chorionic gonadotropin increase in normal early pregnancy. Am J Obstet Gynecol 1987; 156:286-290.
34. Royal College of Obstetricians and Gynaecologists, Guideline No. 17, The Management of Recurrent Miscarriage, London, RCOG, 2003.
35. Christiansen OB, Nybo Andersen AM, Bosch E, Daya S, Delves PJ, Hviid TV, Kutteh WH, Laird SM, Li TC, van der Ven K: Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 2005; 83:821-839.
36. Karaoguz MY, Nas T, Konac E, Ince D, Pala E, Menevse S: Is cytogenetic diagnosis of 46, XX karyotype spontaneous abortion specimens erroneous? Fluorescence in situ hybridization as a confirmatory technique. J Obstet Gynaecol Res 2005; 31:508-513.
37. Bruno DL, Burgess T, Ren H, Nouri S, Pertile MD, Frances DI, Norris F, Kenney BK, Schouten JA, Choo KH, Slater HR: High-throughput analysis of chromosome abnormalities in spontaneous miscarriage using an MPLA subtelomere assay with ancilliary FISH test for polyploidy. Am J Med Genet 2006; 140:2786-2793.
38. Winger E, Reed J, Stricker R: Lymphocyte immunization therapy (LIT) combined with intravenous immunoglobulin (IVIG) improves live birth rates in women with primary recurrent spontaneous abortion. Am J Reprod Immunol 2007; 58:203.
39. Winger EE, Reed JL, Stricker RB: Treatment with tumor necrosis factor (TNF) inhibitors and intravenous immunoglobulin (IVIG) improves live birth rates in women with recurrent spontaneous abortion (RSA). Am J Reprod Immunol 2007; 58:225.
40. Winger EE, Reed JL: Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 2008; 60:8-16.
41. Nielsen HS, Christiansen OB: Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant. Hum Reprod 2005; 20:1720-1728.
42. Clifford K, Rai R, Regan L: Future pregnancy outcome in unexplained first trimester miscarriage. Hum Reprod 1997; 12:387-389.
43. Wieand HS: Randomized Whase II trials: what does randomization gain? J Clin Oncol 2005; 23:1794-1795.
44. Higuchi K, Aoki K, Kimbara T, Hosoi N, Yamamoto T, Okada H: Suppression of natural killer cell activity by monocytes following immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol 1995; 33:221-227.
45. Van den Heuvel MJ, Hatta K, Peralta CG, Han VH, Clark DA: Suppression of elevated blood NKT cells in recurrent pregnancy failure patients given IVIG correlates with successful pregnancy. Am J Reprod Immunol 2007; 58:447-459. (corrigendum 59;547)
46. Nakamura K, Sheps S, Arck PP: Stress and reproductive failure: past notions, present insights and future directions. J Assist Reprod Genet 2008; 25:47-62.
47. Coulam CB, Acacio B, Rinehart JS, Rinehart L, Ng S, Roussev RG: Pregnancy outcome after intralipid infusion among women experiencing early pregnancy loss. Am J Reprod Immunol 2008; 59:472.